Pre-ERCP High Carbohydrate Drinks Improve Patients Recovery
NCT ID: NCT03075280
Last Updated: 2022-08-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
1292 participants
INTERVENTIONAL
2017-04-01
2021-04-17
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pre-operative Carbohydrate Drink to Preserve Peri-operative Insulin Sensitivity
NCT02673502
Effect of Preoperative Oral Carbohydrates on Quality of Recovery
NCT02555020
Preoperative Carbohydrate Loading in Patients Undergoing Day-case Cholecystectomy
NCT03757208
Effect of Early Postoperative Oral Carbohydrate on Postoperative Recovery of the Unilateral Knee Arthroplasty
NCT05867264
Pre-operative Carbohydrates in Diabetic Patients Undergoing CABG
NCT05540249
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
For upper gastrointestinal surgery, high-carbohydrate drinks can be given 2 hours before surgery in order to guarantee the stability of blood glucose and circulation during the operation. It obviously reduce the preoperative thirst, hunger, irritability and even the incidence of postoperative complications.
However ERAS program is rarely studied in ERCP. Theoretically we can use ERAS as a strategy to reduce post-ERCP uncomfortable and complications.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
High carbohydrate liquid diet
No need preoperative fasting more than 6 hours. Uptake 400ml high carbohydrate liquid diet 2 hours before ERCP.
400ml high carbohydrate liquid diet before ERCP
400ml high carbohydrate liquid diet uptake 2 hours before ERCP
Routine ERCP group
Preoperative fasting more than 6 hours as usual.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
400ml high carbohydrate liquid diet before ERCP
400ml high carbohydrate liquid diet uptake 2 hours before ERCP
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age 18-85 years old.
Exclusion Criteria
* Preoperative coexistent diseases: acute pancreatitis, GI tract hemorrhage, severe liver disease, shock, liver or kidney malfunction,
* Diabetes(blood glucose fluctuations)or with complications,
* Intestinal obstruction or other contraindications with feeding and watering,
* Prior surgery of Bismuth Ⅱ and Roux-en-Y,
* Pregnant women,
* Unwillingness or inability to consent for the study.
18 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hepatopancreatobiliary Surgery Institute of Gansu Province
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Xun Li
M.D., Ph. D, Direct of surgery
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Xun Li, M.D., Ph. D.
Role: PRINCIPAL_INVESTIGATOR
Hepatopancreatobiliary Surgery Institute of Gansu Province
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Third Military Medical University
Chongqing, Chongqing Municipality, China
The first hospital of Lanzhou university
Lanzhou, Gansu, China
The Second Affiliated Hospital of Guangzhou Medical University
Guangzhou, Guangdong, China
The Second Hospital of Hebei Medical University
Shijiazhuang, Hebei, China
Tongji medical collage,Huazhong University of science and technology
Wuhan, Hubei, China
Second Xiangya Hospital, Central South University
Changsha, Hunan, China
The First Hospital of Jilin University
Changchun, Jilin, China
General Hospital of Ningxia Medical University
Yingchuan, Ningxia, China
The first affiliated hospital of Xi 'an jiaotong university
Xi'an, Shaanxi, China
Shandong jiaotong Hospital
Jinan, Shandong, China
Xin Hua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Shanghai, Shanghai Municipality, China
Taiyuan Iron and Steel Corporation Hospital
Taiyuan, Shanxi, China
Tianjin Nankai Hospital
Tianjin, Tianjin Municipality, China
The First Teaching Hospital of Xinjiang Medical University
Ürümqi, Xinjiang, China
Shulan Hospital of Zhejiang University
Hangzhou, Zhejiang, China
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Meng W, Leung JW, Wang Z, Li Q, Zhang L, Zhang K, Wang X, Wang M, Wang Q, Shao Y, Zhang J, Yue P, Zhang L, Zhu K, Zhu X, Zhang H, Hou S, Cai K, Sun H, Xue P, Liu W, Wang H, Zhang L, Ding S, Yang Z, Zhang M, Weng H, Wu Q, Chen B, Jiang T, Wang Y, Zhang L, Wu K, Yang X, Wen Z, Liu C, Miao L, Wang Z, Li J, Yan X, Wang F, Zhang L, Bai M, Mi N, Zhang X, Zhou W, Yuan J, Suzuki A, Tanaka K, Liu J, Nur U, Weiderpass E, Li X. Safety of high-carbohydrate fluid diet 2 h versus overnight fasting before non-emergency endoscopic retrograde cholangiopancreatography: A single-blind, multicenter, randomized controlled trial. Chin Med J (Engl). 2024 Jun 20;137(12):1437-1446. doi: 10.1097/CM9.0000000000002820. Epub 2023 Aug 24.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HSIGansu
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.